From user to manufacturer: How substantial modification of medical AI crosses the product liability threshold under the revised PLD.

Ampovska M.

Open source

DOI
10.1016/j.ijlp.2026.102268
Published
2026-08-13
Container
Int J Law Psychiatry
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijlp.2026.102268,
  title = {From user to manufacturer: How substantial modification of medical AI crosses the product liability threshold under the revised PLD.},
  author = {Ampovska M.},
  year = {2026},
  journal = {Int J Law Psychiatry},
  doi = {10.1016/j.ijlp.2026.102268},
  url = {https://doi.org/10.1016/j.ijlp.2026.102268}
}

RIS

TY  - JOUR
TI  - From user to manufacturer: How substantial modification of medical AI crosses the product liability threshold under the revised PLD.
AU  - Ampovska M.
PY  - 2026
JO  - Int J Law Psychiatry
DO  - 10.1016/j.ijlp.2026.102268
UR  - https://doi.org/10.1016/j.ijlp.2026.102268
ER  - 

APA

M., A. (2026). From user to manufacturer: How substantial modification of medical AI crosses the product liability threshold under the revised PLD.. Int J Law Psychiatry. https://doi.org/10.1016/j.ijlp.2026.102268

Source records